Gender differences of acute and chronic administration of dehydroepiandrosterone in rats submitted to the forced swimming test

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 31, Issue 3, 2007, Pages 613-621

  Andrade, S ^a   Silveira, S L ^a   Gomez, R ^b   Barros, H M T ^b   Ribeiro, M F M ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

Author keywords

Corticosterone; Dehydroepiandrosterone; Estral cycle; Forced swimming; Gender; Stress

Indexed keywords

PRASTERONE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLIMBING; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DEPRESSION; DIESTRUS; DRUG EFFECT; DRUG RESPONSE; ESTRUS CYCLE; FEMALE; FORCED SWIMMING TEST; FREEZING; GENDER; HORMONE BLOOD LEVEL; MALE; NONHUMAN; RAT; SEX DIFFERENCE; WISTAR RAT;

ADJUVANTS, IMMUNOLOGIC; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; CORTICOSTERONE; DEHYDROEPIANDROSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; MALE; RATS; RATS, WISTAR; SEX CHARACTERISTICS; SWIMMING;

EID: 33947596852     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2006.12.006     Document Type: Article

References (67)

1. Abel E.L. Physiological correlates of the forced swim test in rats. Physiol Behav 54 2 (1993) 309-317
2. Abel E.L. A further analysis of physiological changes in rats in the forced swim test. Physiol Behav 56 (1994) 795-800
3. Apostolova G., Schweizer R.A., Balazs Z., Kostadinova R.M., and Odermatt A. Dehydroepiandrosterone inhibits the amplification of glucocorticoid action in adipose tissue. Am J Physiol Endocrinol Metabol Gastrointest Physiol 288 5 (2005) E957-E964
4. Arlt W. Dehydroepiandrosterone replacement therapy. Semin Reprod Med 22 4 (2004) 379-388
5. Arlt W. Androgen therapy in women. Eur J Endocrinol 154 1 (2006) 1-11
6. Arlt W., Callies F., and Allolio B. DHEA replacement in women with adrenal insufficiency-pharmacokinetics, bioconversion and clinical effects on well-being, sexuality and cognition. Endocr Res 26 4 (2000) 505-511
7. Barros H.M.T., and Ferigolo M. Ethopharmacology of imipramine in the forced-swimming test: gender differences. Neurosci Biobehav Rev 23 (1998) 279-286
8. Baulieu E.E. Steroid hormone receptors. Expos Annu Biochim Med 34 (1980) 1-25
9. Baulieu E.E., Robel P., and Schumacher M. Neurosteroids: from definition and biochemistry to physiopathology function. In: Baulieu E.E., Robel P., and Shumacher M. (Eds). Neurosteroids: a new regulatory function in the nervous system (1999), Humana Press, Totowa 1-25
10. Beiko J., Lander R., Hampson E., Boon F., and Cain C.P. Contribution of sex differences in the acute stress response to sex differences in water maze performance in the rat. Behav Brain Res 151 1-2 (2004) 239-253
11. Brotto L.A., Barr A.M., and Gorzalka B.B. Sex differences in forced-swim and open-field test behaviours after chronic administration of melatonin. Eur J Pharmacol 18;402 1-2 (2000) 87-93
12. Brotto L.A., Gorzalka B.B., and Barr A.M. Paradoxical effects of chronic corticosterone on forced swim behaviours in aged male and female rats. Eur J Pharmacol 27;424 3 (2001) 203-209
13. Cameron D.R., and Braunstein G.D. The use of dehydroepiandrosterone therapy in clinical practice. Treat Endocrinol 4 2 (2005) 95-114
14. Cohen L.S., Soares C.N., Vitonis A.F., Otto M.W., and Harlow B.L. Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry 63 4 (2006) 385-390
15. Compagnone N.A., and Mellon S.H. Dehydroepiandrosterone: a potential signalling molecule for neocortical organization during development. Proc Natl Acad Sci U S A 14;95 8 (1998) 4678-4683
16. Consoli D., Fedotova J., Micale V., Sapronov N.S., and Drago F. Stressors affect the response of male and female rats to clomipramine in a model of behavioral despair (forced swim test). Eur J Pharmacol 27;520 1-3 (2005) 100-107
17. Cotton S.M., Wright A., Harris M.G., Jorm A.F., and McGorry P.D. Influence of gender on mental health literacy in young Australians. Aust N Z J Psychiatry 40 9 (2006) 790-796
18. Dalla C., Antoniou K., Drossopoulou G., Xagoraris M., Kokras N., Sfikakis A., et al. Chronic mild stress impact: are females more vulnerable?. Neuroscience 135 3 (2005) 703-714
19. David D.V., Dhonnchadha B.A., Jolliet P., Hascoet M., and Bourin M. Are there gender differences in the temperature profile of mice after acute antidepressant administration and exposure to two animal models of depression. Behav Brain Res 119 2 (2001) 203-211
20. Drossopoulou G., Antoniou K., Kitraki E., Papathanasiou G., Papalexi E., Dalla C., et al. Sex differences in behavioral, neurochemical and neuroendocrine effects induced by the forced swim test in rats. Neuroscience 126 4 (2004) 849-857
21. Fabian T.J., Dew M.A., Pollock B.J., Reynolds C.F., Mulsant B.H., Butters M.A., et al. Endogenous concentrations of DHEA and DHEA-S decrease with remission of depression in older adults. Biol Psychiatry 50 10 (2001) 767-774
22. Ferigolo M., Barros H.M.T., Marquardt A.R., and Tannhauser M. Comparison of behavioral effects of moclobemide and deprenyl during forced-swimming. Pharmacol Biochem Behav 60 (1998) 431-437
23. Finckh A., Berner I.C., Aubry-Rozier B., and So A.K. A randomized controlled trial of dehydroepiandrosterone in postmenopausal women with fibromyalgia. J Rheumatol 32 7 (2005) 1336-1340
24. Gadek-Michalska A., and Bugajski J. Repeated handling, restraint, or chronic crowding impair the hypothalamic-pituitary-adrenocortical response to acute restraint stress. J Physiol Pharmacol 54 3 (2003) 449-459
25. Galea L.A., Lee T.T., Kostaras X., Sidhu J.A., and Barr A.M. High levels of estradiol impair spatial performance in the Morris water maze and increase depressive-like behaviors in the female meadow vole. Physiol Behav 77 2-3 (2002) 217-225
26. Gomez R., and Barros H.M.T. Ethopharmacology of the antidepressant effect of clonazepam in diabetic rats. Pharmacol Biochem Behav 66 2 (2000) 329-335
27. Guide for the Care and Use of Laboratory Animals. Institute of Laboratory Animal Research, National Research Council (1996), National Academies Press 140 pp.
28. Heuser I., Deuschle M., Luppa P., Schweiger U., Standhardt H., and Weber B. Increased diurnal plasma concentrations of dehydroepiandrosterone in depressed patients. J Clin Endocrinol Metab 83 9 (1998) 3130-3133
29. Ising M., Heike E.K., Binder E.B., Nickel T., Modell S., and Holsboer F. The combined dexamethasone/CRH test as a potential surrogate marker in depression. Prog Neuropsychopharmacol Biol Psychiatry 29 (2005) 1085-1093
30. Jozuka H., Jozuka E., Takeuchi S., and Nishikaze O. Comparison of immunological and endocrinological markers associated with major depression. J Int Med Res 31 1 (2003) 36-41
31. Kant G.J., Lenox R.H., Bunnell B.N., Mougey E.H., Pennington L.I., and Meyerhoff J.L. Comparison of stress response in male and female rats: pituitary cyclic AMP and plasma prolactin, growth hormone and corticosterone. Psychoneuroendocrinology 8 4 (1983) 421-428
32. Kaur G., and Kulkarni S.K. Evidence for serotonergic modulation of progesterone-induced hyperphagia, depression and algesia in female mice. Brain Res 12;943 2 (2002) 206-215
33. Kennett G.A., Chaouloff F., Marcou M., and Curzon G. Female rats are more vulnerable than males in an animal model of depression: the possible role of serotonin. Brain Res 382 2 (1986) 416-421
34. Kessler R.C., McGonagle K.A., Swartz M., Blazer D.G., and Nelson C.B. Sex and depression in the National Comorbidity Survey. I: lifetime prevalence, chronicity and recurrence. J Affect Disord 29 2-3 (1993) 85-96
35. Kessler R.C., McGonagle K.A., Zhao S., Nelson C.B., Hughes M., Eshleman S., et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51 1 (1994) 8-19
36. Kimonides V.G., Spillantini M.G., Sofroniew M.V., Fawcett J.W., and Herbert J. Dehydroepiandrosterone antagonizes the neurotoxic effects of corticosterone and translocation of stress-activated protein kinase 3 in hippocampal primary cultures. Neuroscience 89 2 (1999) 429-436
37. Laughlin G.A., and Barrett-Connor E. Sexual dimorphism in the influence of advanced aging on adrenal hormone levels: the Rancho Bernardo Study. J Clin Endocrinol Metab 85 10 (2000) 3561-3568
38. Lopez-Rubalcava C., and Lucki I. Strain differences in the behavioral effects of antidepressant drugs in the rat forced swimming test. Neuropsychopharmacology 22 2 (2000) 191-199
39. Luisi S., Petraglia F., Benedetto C., Nappi R.E., Bernardi F., Fadalti M., et al. Serum allopregnanolone levels in pregnant women: changes during pregnancy, at delivery, and in hypertensive patients. J Clin Endocrinol Metab 85 7 (2001) 2429-2433 [2000 Jul]
40. Majewska M.D., Demirgoren S., and London E.D. Binding of pregnenolone sulfate to rat brain membranes suggests multiple sites of steroid action at the GABAA receptor. Eur J Pharmacol 30;189 4-5 (1990) 307-315
41. Majewska M.D., Demirgoren S., Spivak C.E., and London E.D. The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAA receptor. Brain Res 27;526 1 (1990) 143-146
42. Mao X., and Barger S.W. Neuroprotection by dehydroepiandrosterone-sulfate: role of an NFkappaB-like factor. Neuroreport 9;9 4 (1998) 759-763
43. Merkatz R.B., Temple R., Subel S., Feiden K., and Kessler D.A. Women in clinical trials of new drugs. A change in food and drug administration policy. The working group on women in clinical trials. N Engl J Med 329 4 (1993) 292-296
44. Monnet F.P., Mahe V., Robel P., and Baulieu E.E. Neurosteroids, via sigma receptors, modulate the [3H]norepinephrine release evoked by N-methyl-d-aspartate in the rat hippocampus. Proc Natl Acad Sci U S A 25;92 9 (1995) 3774-3778
45. Nguyen T., Porter J., and Svec F. Dehydroepiandrosterone (DHEA) decreases open-field spontaneous activity of Zucker rats. Physiol Behav 67 5 (1999) 725-731
46. Pariante C.M. Depression, stress and the adrenal axis. J Neuroendocrinol 15 8 (2003) 811-812
47. Pariante C.M. Glucocorticoid receptor function in vitro in patients with major depression. Stress 7 4 (2004) 209-219
48. Paul S.M., and Purdy R.H. Neuroactive steroids. FASEB J 6 6 (1992) 2311-2322
49. Pham J., Porter J., Svec D., Eiswirth C., and Svec F. The effect of dehydroepiandrosterone on Zucker rats selected for fat food preference. Physiol Behav 15;70 5 (2000) 431-441
50. Porsolt R.D., Le Pichon M., and Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 266 (1977) 730-732
51. Porsolt R.D., Anton G., Blavet N., and Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 47 (1978) 379-391
52. Prasad A., Imamura M., and Prasad C. Dehydroepiandrosterone decreases behavioral despair in high-but not low-anxiety rats. Physiol Behav 62 (1997) 1053-1057
53. 1) receptor mediated anti-depressant-like effects of neurosteroids in the Porsolt forced swim test. Neuroreport 9 13 (1998) 3069-3073
54. Ribeiro M.F., Ferigolo M., Reis F.M., Barros H.M., and Spritzer P.M. Paradoxical effect of imipramine in hyperprolactinemic female rats exposed to the forced swimming test. Physiol Behav 68 5 (2000) 619-623
55. Sagud M., Hotujac L.J., Mihaljevic-Peles A., and Jakovljevic M. Gender differences in depression. Coll Antropol 26 1 (2002) 149-157
56. Schmidt P.J., Murphy J.H., Haq N., Danaceau M.A., and St Clair L. Basal plasma hormone level in depressed perimenopausal women. Psychoneuroendrocrinology 27 8 (2002) 907-920
57. Schmidt P.J., Daly R.C., Bloch M., Smith M.J., Danaceau M.A., St Clair L.S., et al. Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression. Arch Gen Psychiatry 62 2 (2005) 154-162
58. Schumacher M., Guennoun R., Robel P., and Baulieu E.E. Neurosteroids in the hippocampus: neuronal plasticity and memory. Stress 2 1 (1997) 65-78
59. Serra M., Pisu M.G., Littera M., Papi G., Sanna E., Tuveri F., et al. Social isolation-induced decreases in both the abundance of neuroactive steroids and GABA(A) receptor function in rat brain. J Neurochem 75 2 (2000) 732-740
60. A - antagonistic neurosteroids I patients with combat-related post-traumatic stress disorder. Psychol Med 30 5 (2000) 1227-1231
61. Stefanski V., and Gruner S. Gender difference in basal and stress levels of peripheral blood leukocytes in laboratory rats. Brain Behav Immun 20 4 (2006) 369-377
62. 1 receptor agonists and neuroactive steroids in mice submitted to the forced swimming test. J Pharmacol Exp Ther 298 3 (2001) 1269-1279
63. Walf A.A., Sumida K., and Frye C.A. Inhibiting 5alpha-reductase in the amygdala attenuates antianxiety and antidepressive behavior of naturally receptive and hormone-primed ovariectomized rats. Psychopharmacology (Berl) 186 3 (2006) 302-311
64. Waller M.W., Hallfors D.D., Halpern C.T., Iritani B.J., Ford C.A., and Guo G. Gender differences in associations between depressive symptoms and patterns of substance use and risky sexual behavior among a nationally representative sample of U.S. adolescents. Arch Womens Ment Health 9 3 (2006) 139-150
65. Wilson M.A., and Biscardi R. Sex differences in GABA/benzodiazepine receptor changes and corticosterone release after acute stress in rats. Exp Brain Res 101 2 (1994) 297-306
66. Wolkowitz O.M., Reus V.I., Keebler A., Nelson N., Friedland M., Brizendine L., et al. Double-blind treatment of major depression with dehydroepiandrosterone. Am J Psychiatry 156 4 (1999) 646-649
67. Young A.H., Gallagher P., and Porter R.J. Elevation of the cortisol-dehydroepiandrosterone ratio in drug-free depressed patients. Am J Psychiatry 159 7 (2002) 1237-1239